Cargando…

Correlates of Vaccine-Induced Protection against SARS-CoV-2

We are in the midst of a pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19). SARS-CoV-2 has caused more than two million deaths after one year of the pandemic. The world is experiencing a deep economic reces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koch, Till, Mellinghoff, Sibylle C., Shamsrizi, Parichehr, Addo, Marylyn M., Dahlke, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035658/ https://www.ncbi.nlm.nih.gov/pubmed/33801831 http://dx.doi.org/10.3390/vaccines9030238

Ejemplares similares

Characterization of Individuals Interested in Participating in a Phase I SARS-CoV-2 Vaccine Trial
por: Shamsrizi, Parichehr, et al.
Publicado: (2021)

Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens
por: Weskamm, Leonie M., et al.
Publicado: (2022)

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

2343. SARS-CoV-2 Spike Conformation Essentially Influences Vaccine Immunogenicity – Results from Two Clinical Phase I Trials of the Vector Vaccine Candidates MVA-SARS-2-S and MVA-SARS-2-ST
por: Fathi, Anahita, et al.
Publicado: (2023)

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

SARS-CoV-2 vaccination in CLL: how often is enough?
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Sex Differences in Immunity: Implications for the Development of Novel Vaccines Against Emerging Pathogens
por: Fathi, Anahita, et al.
Publicado: (2021)

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
por: Badbaran, Anita, et al.
Publicado: (2021)

A simple, sensitive, and low‐cost FACS assay for detecting antibodies against the native SARS‐CoV‐2 spike protein
por: Hambach, Julia, et al.
Publicado: (2021)

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
por: Weskamm, Leonie M., et al.
Publicado: (2022)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019)

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
por: Meyer zu Natrup, Christian, et al.
Publicado: (2022)

The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing
por: Hassanzadeh, Parichehr
Publicado: (2021)

Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques
por: McMahan, Katherine, et al.
Publicado: (2020)

Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia
por: Sorcini, Daniele, et al.
Publicado: (2022)

1356. "Correlates of protection against SARS-CoV-2 post-vaccine infections in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study"
por: Goguet, Emilie, et al.
Publicado: (2023)

Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
por: Hagemann, Kerri, et al.
Publicado: (2022)

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
por: Feng, Shuo, et al.
Publicado: (2021)

DNA vaccine protection against SARS-CoV-2 in rhesus macaques
por: Yu, Jingyou, et al.
Publicado: (2020)

BCG vaccination provides protection against IAV but not SARS-CoV-2
por: Kaufmann, Eva, et al.
Publicado: (2022)

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Managing waning vaccine protection against SARS-CoV-2 variants
por: Leung, Kathy, et al.
Publicado: (2022)

Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
por: Sui, Yongjun, et al.
Publicado: (2021)

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
por: Addo, Isaac Yeboah, et al.
Publicado: (2022)

Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
por: Hensel, Janine, et al.
Publicado: (2020)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Correlates of protection from SARS-CoV-2 infection
por: Krammer, Florian
Publicado: (2021)

Traveling into the Abyss: Risk Perception of German Travelers at the Onset of the COVID-19 Pandemic
por: Shamsrizi, Parichehr, et al.
Publicado: (2020)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
por: Hall, Victoria, et al.
Publicado: (2022)

Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques
por: Sui, Yongjun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nh31iv4qq5rtedcbajkfild0i3